Home 2023

Cardiomyopathies

StockWatch: For Genome Editing, Inflection Points Crowd the Calendar
GEN Edge

StockWatch: For Genome Editing, Inflection Points Crowd the Calendar

Alex Philippidis -
0
Immunotherapy-Related Myocarditis Linked to T Cells Targeting Cardiac-Specific Antigen
Cancer

Immunotherapy-Related Myocarditis Linked to T Cells Targeting Cardiac-Specific Antigen

Sophia Ktori -
0
Gene Therapy Pioneers Share Genome Editing Insights at Chardan Conference
Drug Discovery

Gene Therapy Pioneers Share Genome Editing Insights at Chardan Conference

Alex Philippidis -
0
Five Startups Enliven the Gene Therapy Scene in Asia
Drug Discovery

Five Startups Enliven the Gene Therapy Scene in Asia

Kathy Vuksanaj -
0
Biomolecular Condensates Might Revolutionize Drug Discovery
Cancer

Biomolecular Condensates Might Revolutionize Drug Discovery

John Sterling -
0
Novel Artificial Intelligence Tool Identifies Hard-to-Miss Heart Conditions
Artificial Intelligence

Novel Artificial Intelligence Tool Identifies Hard-to-Miss Heart Conditions

Christina Jackson -
0
Bagging the Culprit: Japanese Researchers Identify BAG5 Mutations as Cause of Dilated Cardiomyopathy
News

Bagging the Culprit: Japanese Researchers Identify BAG5 Mutations as Cause of Dilated Cardiomyopathy

Kathy Vuksanaj -
0
Bristol-Myers Squibb to Acquire MyoKardia for $13.1B, Expanding Cardiovascular Franchise
Drug Discovery

Bristol-Myers Squibb to Acquire MyoKardia for $13.1B, Expanding Cardiovascular Franchise

Alex Philippidis -
0
Applied Therapeutics
News

Applied Therapeutics

Alex Philippidis -
0
Moderate Drinking Could Increase Survival in Older Heart Failure Patients
Featured

Moderate Drinking Could Increase Survival in Older Heart Failure Patients

Sophia Ktori -
0
123Page 1 of 3
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.